We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Reference sheet · Cell Adhesion · CPC catalog code LAMN-001
Composition figures above are derived arithmetically from the published sequence for the unmodified free peptide. Salt forms (commonly trifluoroacetate or acetate), amidation, and other modifications shift the observed mass — always reconcile against the current lot certificate of analysis.
Volumes for a 1 mg vial of Laminin A Chain (2091-2108) at common working concentrations. Add solvent slowly down the vial wall and swirl — do not vortex or shake.
Reference standards in the Cell Adhesion class are typically shipped as lyophilized powder and stored desiccated at −20 °C protected from light. Once reconstituted in bacteriostatic water or the assay-appropriate buffer, aliquot and store at −80 °C to minimize freeze–thaw cycles. Confirm handling requirements against your institutional biosafety and radiation protocols before use.
Laminin A Chain (2091-2108) sits within the Cell Adhesion research class (CPC reference LAMN-001). Cell-adhesion peptides present short recognition motifs (RGD, YIGSR, IKVAV, and related sequences) that engage integrins and matrix receptors, allowing controlled studies of attachment, spreading, migration, and outside-in signaling. Investigators typically incorporate Laminin A Chain (2091-2108) as a reference standard, tool ligand, or substrate in the assay contexts listed above. Typically used in coated-plate attachment assays, transwell migration, and SPR / BLI integrin-binding measurements.
Laminin A Chain (2091-2108) (CPC catalog code LAMN-001) is a synthetic cell adhesion / ecm peptide in the cell adhesion category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
Published and internal research programs use Laminin A Chain (2091-2108) as a reference standard in cell adhesion workflows — for example, integrin engagement and blocking studies and migration and wound-closure assays. Human clinical evidence is not established.
No. Laminin A Chain (2091-2108) is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
In a cell adhesion workflow, Laminin A Chain (2091-2108) is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. Typically used in coated-plate attachment assays, transwell migration, and SPR / BLI integrin-binding measurements.
Other reference standards in the same class — commonly cross-referenced during assay design and comparator selection.